ROCKVILLE, Md., Nov. 30 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that the company will be presenting at the 21st Annual Health Care Conference 2009 on December 2, 2009 at 12:30 pm local time at The New York Palace, New York. Novavax will provide an overview of the company's business strategy, research and development progress and upcoming milestones. A link to the live audio only presentation can be accessed via the Company website at www.novavax.com under the Investors tab. An archive of the presentation will be available one hour after the event on the Novavax website for 90 days.
About the Piper Jaffray Healthcare Conference
Piper Jaffray hosts several client conferences and events each year focusing on the consumer, health care, financial services, alternative energy and technology sectors. The goal of each conference is to bring together key industry executives, investors and Piper Jaffray professionals to provide multiple perspectives, investigate critical trends and identify the leaders in the markets that are driving the economy.
Novavax, Inc. is a clinical-stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology. The company produces potent VLP -based recombinant vaccines utilizing new and efficient manufacturing approaches. Novavax is committed to using its VLP technology to create country-specific vaccine solutions. The company has formed a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India. Additio
|SOURCE Novavax, Inc.|
Copyright©2009 PR Newswire.
All rights reserved